News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Epizyme (EPZM) To Present At Upcoming Conferences In September


8/26/2014 9:54:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five upcoming conferences in September:

•Citi 9th Annual Biotech Conference at the Mandarin Oriental Boston on Wednesday, September 3. Epizyme Chief Executive Officer Robert Gould, Ph.D., will participate in a panel titled “Novel Therapies for Blood Disorders: Making Big Strides vs. Baby Steps” at 2 p.m. ET.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Epizyme
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES